first choice in treating

Over the years relevant to diuretikam, as antigipertenzivnym drugs significantly altered. But now it is safe to say that diuretiki is one of the most valuable classes antigipertnezivnyh funds, as shown by both international and national recommendations for treatment AG. The value of these products and their positive impact on cardiovascular morbidity and mortality have been documented in numerous multicentric prospective studies [6]. In recent years, provide important data that the effectiveness and ability to prevent the development of cardiovascular disease, they are not inferior to the so-called "new" products. Diuretiki and is widely used in the treatment of adolescent AG. In the second report of the Working Group to monitor the high blood pressure in children and adolescents (1987) diuretiki along with b-blokatorami were attributed to the typical first choice in treating AG in this category of patients. A proposed scheme arterial hypertension treatment (Fig. 1). Subsequently, the concept has been revised with respect to the first drugs of choice. Along with diuretikami and b-blokatorami group for first-choice were included calcium antagonists and ACE inhibitors. Nevertheless, in addition to the second report of the Working Group on monitoring high blood pressure in 1996 highlighted the important role diuretikov treatment AG in children and adolescents. Scheme phases drug therapy in children and adolescents (1987), Fig. 1. Scheme phases drug therapy in children and adolescents (1987) Some authors consider that the AG for the treatment of adolescents can be used three main classes of drugs diureticheskih : tiazidnye and tiazidopodobnye diuretiki, petlevye diuretiki and kaliysberegayuschie diuretiki [7,8]. Thus, for patients with AG in conjunction with kidney disease, especially if kidney failure, it is recommended furosemide.